Gonzalez R, Pons-Duran C, Piqueras M, Aponte J, Kuile F, Menendez C
Cochrane Database Syst Rev. 2018; 11:CD011444.
PMID: 30480761
PMC: 6517148.
DOI: 10.1002/14651858.CD011444.pub3.
Gonzalez R, Pons-Duran C, Piqueras M, Aponte J, Kuile F, Menendez C
Cochrane Database Syst Rev. 2018; 3:CD011444.
PMID: 29561063
PMC: 5875065.
DOI: 10.1002/14651858.CD011444.pub2.
Lobo L, de Sousa B, Cabral L, Cristiano M, Nogueira F
Mem Inst Oswaldo Cruz. 2016; 0.
PMID: 27276364
PMC: 4957497.
DOI: 10.1590/0074-02760160077.
Quashie N, Duah N, Abuaku B, Quaye L, Ayanful-Torgby R, Akwoviah G
Malar J. 2013; 12:450.
PMID: 24341604
PMC: 3878558.
DOI: 10.1186/1475-2875-12-450.
Gharbi M, Flegg J, Hubert V, Kendjo E, Metcalf J, Bertaux L
Malar J. 2013; 12:35.
PMID: 23351608
PMC: 3583707.
DOI: 10.1186/1475-2875-12-35.
Sontochin as a guide to the development of drugs against chloroquine-resistant malaria.
Pou S, Winter R, Nilsen A, Kelly J, Li Y, Doggett J
Antimicrob Agents Chemother. 2012; 56(7):3475-80.
PMID: 22508305
PMC: 3393441.
DOI: 10.1128/AAC.00100-12.
Optimization of endochin-like quinolones for antimalarial activity.
Winter R, Kelly J, Smilkstein M, Hinrichs D, Koop D, Riscoe M
Exp Parasitol. 2010; 127(2):545-51.
PMID: 21040724
PMC: 3025093.
DOI: 10.1016/j.exppara.2010.10.016.
An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia.
Whitman T, Coyne P, Magill A, Blazes D, Green M, Milhous W
Am J Trop Med Hyg. 2010; 83(2):258-65.
PMID: 20682864
PMC: 2911167.
DOI: 10.4269/ajtmh.2010.09-0774.
pfmdr1 amplification associated with clinical resistance to mefloquine in West Africa: implications for efficacy of artemisinin combination therapies.
Witkowski B, Iriart X, Soh P, Menard S, Alvarez M, Naneix-Laroche V
J Clin Microbiol. 2010; 48(10):3797-9.
PMID: 20668121
PMC: 2953132.
DOI: 10.1128/JCM.01057-10.
Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.
Witkowski B, Nicolau M, Soh P, Iriart X, Menard S, Alvarez M
Antimicrob Agents Chemother. 2010; 54(7):3049-51.
PMID: 20404118
PMC: 2897320.
DOI: 10.1128/AAC.00209-10.
Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.
Bacon D, Tang D, Salas C, Roncal N, Lucas C, Gerena L
PLoS One. 2009; 4(8):e6762.
PMID: 19707564
PMC: 2728505.
DOI: 10.1371/journal.pone.0006762.
Synthesis and biological evaluation of febrifugine analogues as potential antimalarial agents.
Zhu S, Zhang Q, Gudise C, Wei L, Smith E, Zeng Y
Bioorg Med Chem. 2009; 17(13):4496-502.
PMID: 19467876
PMC: 2746662.
DOI: 10.1016/j.bmc.2009.05.011.
Antimalarial quinolones: synthesis, potency, and mechanistic studies.
Winter R, Kelly J, Smilkstein M, Dodean R, Hinrichs D, Riscoe M
Exp Parasitol. 2007; 118(4):487-97.
PMID: 18082162
PMC: 2323441.
DOI: 10.1016/j.exppara.2007.10.016.
Antimalarial activities of new pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives.
Guan J, Zhang Q, ONeil M, Obaldia 3rd N, Ager A, Gerena L
Antimicrob Agents Chemother. 2005; 49(12):4928-33.
PMID: 16304154
PMC: 1315943.
DOI: 10.1128/AAC.49.12.4928-4933.2005.
Halofantrine: a new substance for treatment of multidrug-resistant malaria.
Nothdurft H, Clemens R, Bock H, Loscher T
Clin Investig. 1993; 71(1):69-73.
PMID: 8453264
DOI: 10.1007/BF00210972.
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.
Palmer K, Holliday S, Brogden R
Drugs. 1993; 45(3):430-75.
PMID: 7682911
DOI: 10.2165/00003495-199345030-00009.
Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome.
Slutsker L, Khoromana C, Payne D, Allen C, Wirima J, Heymann D
Bull World Health Organ. 1990; 68(1):53-9.
PMID: 2189586
PMC: 2393017.
Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children.
Ekanem O, Weisfeld J, Salako L, Nahlen B, Ezedinachi E, Walker O
Bull World Health Organ. 1990; 68(1):45-52.
PMID: 2189585
PMC: 2393001.
Prevention of malaria.
Keystone J
Drugs. 1990; 39(3):337-54.
PMID: 2184005
DOI: 10.2165/00003495-199039030-00002.
Treatment of malaria--1990.
Panisko D, Keystone J
Drugs. 1990; 39(2):160-89.
PMID: 2183998
DOI: 10.2165/00003495-199039020-00002.